N
avi Mumbai city witnessed an
unprecedented rise in cases of Hand, Foot and Mouth Disease (HFMD) in
July-October 2018 with two children reporting recurrences in the same
year and lesions extending beyond the characteristic distribution over
the body. Clinical characteristics were studied and the virological and
molecular laboratory diagnosis was carried out to identify the
etiological agents.
All children with clinical suspicion of HFMD upto age
18 years during the study period September- October 2018 were included.
Stool specimens along with swabs from the throat and vesicles were
collected from these children. The specimens (stool, vesicle fluid and
throat swabs) were transported in cold chain to the ICMR-National
Institute of Virology, Mumbai Unit, Mumbai for molecular diagnosis and
virus isolation.Written consent for specimen collection was obtained
from the parents of the children by the hospital authorities.
Enterovirus (EV) isolation was performed as per the WHO Laboratory
Manual protocol (2004) by inoculating human rhabdomyosarcoma (RD) cells.
The cultures briefly were incubated at 36
oC
and cytopathic effect (CPE) was observed for five days. Once CPE was
observed, tissue culture material was harvested for RNA extraction using
QIAGEN Mini RNA Extraction Kit according to the manufacturer’s
instructions. Clinical specimens were used for RNA extraction for direct
detection of enteroviruses. Partial VP1 (RT-snPCR) was performed using
primers as shown in Table I.
TABLE I Primers used for EV PCR Amplification and Sequencing
Primers |
Sequences (5’-3’) |
Region |
Nucleotide positions |
AN89 |
CAGCACTGACAGCAGYNGARAYNGG |
VP1 |
2602-2627 |
AN88 |
TACTGGACCACCTGGNGGNAYRWACAT |
VP1 |
2977-2951 |
224 |
GCIATGYTIGGIACICAYRT |
VP3 |
1977-1996 |
222 |
CICCIGGIGGIAYRWACAT |
VP1 |
2969-2951 |
011 |
GCICCIGAYTGITGICCRAA |
2A |
3408–3389 |
240 |
ATICCICCRCARTCICCIGG |
2A |
3690-3671 |
A total of 17 (four stool, nine vesicle fluids and
four throat swabs) specimens were collected from 15 HFMD cases. Stool
and vesicle fluid specimens were collected simultaneously from only 2
cases whereas only one specimen was collected from the remaining cases.
Of the 15 HFMD cases aged between nine months and 12 years, 13 (13/15)
were confirmed to be caused by EV. EV was isolated by culture from
different specimens (4/4 stool, 4/9 vesicle fluids and 1/4 throat
swabs). Stool specimens yielded highest virus isolations as compared to
swabs from vesicles. In 4 children, EV was detected from clinical
samples by RT-PCR alone.
Coxsackievirus A6 (CV-A6) was detected in ten cases
while Coxsackievirus A16 (CV-A16) was reported in three cases. No mixed
infection due to either CVA6 or CVA16 was observed from any case.
Interestingly, three children identified with CV-A6
had extensive rashes, extending to the trunk. Out of these three cases,
two had previous history of HFMD. A 2-year-old female child from China
excreted CV-A16 in the stool. She was vaccinated twice against
enterovirus-A71 (EV-A71) vaccine in China in 2017. No complications were
reported in any case.
HFMD presents as sudden appearance in crops of
erythematous papulovesicular rashes with a characteristic distribution
over the hands, feet, knees, buttocks and intraoral areas. It is
commonly seen in children less than 10 years. It is mostly caused by
CV-A16 and EV-A71, but can also be caused by serotypes CV-A 2-8, 10, 12
and 14 [1]. The diagnosis of HFMD in India is usually clinical due to
limited availability of molecular testing. The disease is by and large
self-limiting and resolves within 7-10 days. However, neurological
and/or cardiopulmonary complications such as encephalitis, aseptic
meningitis, pulmonary oedema and cardio respiratory failure can occur in
about 1% of HFMD patients. EV-A71 infections are more severe than CV-A16
across all ages [2].
Recurrences occurred in two cases which could be due
to absence of immunity or due to infection with another enterovirus
serotype. Extensive lesions over trunks in HFMD with CV-A6 have been
reported in Japan [3]. CV-A16 and CV-A6 have also been identified as
major causes of HFMD in Southern and Eastern parts of India [4,5].
EV-A71 vaccines are available in mainland China with
>90% protective efficacy against EV-A71-associa-ted HFMD [6].
Cross-protection of EV-A71 vaccine to CV-A16 infections does not occur
[7].
A similar HFMD outbreak was reported during May-June
2018 in South Mumbai, which is about 25 km away from Navi Mumbai [8].
The phylogenetic analysis of CV-A6 and CV-A16 viruses isolated from
these cases from both outbreaks showed that they are genetically closely
related (Data not shown).
Co-circulation of CV-A6 and CV-A16 was observed in
the reported HFMD outbreak in Navi Mumbai, highlighting an urgent need
of virological surveillance to study recurrences and the changing
clinical pattern of the disease.
Acknowledgements: Dr Vijay Yewale, Director of Dr
Yewale’s Hospital for Children, Navi Mumbai for supporting the study. Dr
Mangai Sinha, Dr Vikram Patra, Dr Shruti Kalkekar, Dr Manohar K, Dr
Santosh Kangule for referring their patients for this study. Dr DT
Mourya, Director, NIV, Pune for his interest in the work and support.
Contributors: DD,VK: conceptualized the study
design. DD,VK,SP,TQ,PS: contributed to data collection and analysis. All
the authors provided critical inputs into manuscript writing, and
approved its final version
Funding: This work was supported by intramural
grant from ICMR.
Competing interest: None stated.
References
1. Dharmapalan D. Non Polio enteroviruses. In:
Kundu R, Shastri D, chief editors. FAQs in Pediatric Infectious
Diseases. 1st Ed. New Delhi: Jaypee Brothers; 2014. p.94-7.
2. Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT,
et al. Hand, foot, and mouth disease in China, 2008-12: An
epidemiological study. Lancet Infect Dis. 2014;14:308-18.
3. Kobayashi M, Makino T, Hanaoka N, Shimizu H, Enomoto
M, Okabe N, et al. Clinical manifestations of coxsackievirus A6
infection associated with a major outbreak of hand, foot, and mouth
disease in Japan. Jpn J Infect Dis. 2013;66:260-1.
4. Vijayaraghavan PM, Chandy S, Selvaraj K, Pulimood
S, Abraham AM. Virological investigation of hand, foot, and mouth
disease in a tertiary care center in South India. J Glob Infect Dis.
2012;4:153-61.
5. Gopalkrishna V1, Patil PR, Patil GP, Chitambar SD.
Circulation of multiple enterovirus serotypes causing hand, foot and
mouth disease in India. J Med Microbiol. 2012;61:420-5.
6. Chong P, Liu CC, Chow YH, Chou AH, Klein M. Review
of enterovirus 71 vaccines. Clin Infect Dis. 2015;60:797-803.
7. Aswathyraj S, Arunkumar G, Alidjinou EK. Hand,
foot and mouth disease (HFMD): emerging epidemiology and the need for a
vaccine strategy. 2016;205:397.
8. Rising Cases of foot, hand and mouth infection in
South Mumbai.Mumbai Mirror. 2018 May 8; Mumbai. Available from:
https://mumbaimirror.indiatimes.com / mumbai/
cover-story/rising-cases-of-foot-hand-and-mouth-infection-in-south-mumbai/articleshow/64071077.cms.
Accessed November 28, 2018.